Table 1.
Sample size calculations for RECOVER-Pregnancy cohort.
Fig 1.
Study procedures for RECOVER-Adult.
A schematic of the relationship between pregnant individuals and their offspring, and the distribution of acute and post-acute SARS-CoV-2 infection is included in Fig 2. For adult participants, the pregnant cohort simply represents a predefined portion of the participants to ensure that PASC following SARS-CoV-2 infection during pregnancy can be examined and to examine differential effects when SARS-CoV-2 is acquired during pregnancy.
Fig 2.
Schematic representation of planned enrollment for RECOVER-Pregnancy cohort.
RECOVER-Pregnancy cohort includes pregnant individuals (both with and without SARS-CoV-2 during pregnancy) and the pediatric in utero exposure cohort. Acute infection is infection within the last 30 days and post-acute infection is infection during pregnancy, but at a time that was more than 30 days from the date of enrollment.
Table 2.
RECOVER-Adult study procedure modifications for pregnant, breastfeeding, or postpartum individuals.
Fig 3.
Study assessment schedule for children enrolled in RECOVER-Pregnancy.
Visual depiction of the study assessment scheduled for the children enrolled in RECOVER-Pregnancy or the in utero exposure cohort of RECOVER.